Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-23
1995-12-26
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514256, 514342, 514360, 514375, 514376, A61K 3144, A61K 31425, A61K 3141
Patent
active
054788528
ABSTRACT:
Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations experiencing impaired glucose intolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4438141 (1984-03-01), Kawamatsu et al.
patent: 4444779 (1984-04-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4687777 (1987-08-01), Meguro et al.
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4873255 (1989-10-01), Yoshioka et al.
patent: 4897393 (1990-01-01), Iijima et al.
patent: 4897405 (1990-01-01), Alessi et al.
patent: 4918091 (1990-04-01), Cantello et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 5002953 (1991-03-01), Hindley
patent: 5061717 (1991-10-01), Clark et al.
patent: 5120754 (1992-06-01), Clark et al.
patent: 5132317 (1992-07-01), Cantello et al.
patent: 5194443 (1993-03-01), Hindley
patent: 5223522 (1993-06-01), Clark et al.
patent: 5232925 (1993-08-01), Hindley
patent: 5260445 (1993-11-01), Hindley et al.
Saad et al, The New England Journal of Medicine, vol. 319, No. 23 (Dec. 8, 1988) pp. 1500-1506.
Japan Diabetic Society, vol. 31, Supplement 1, (May 1988) Abstracts VII-7 and 207.
Horikoshi et al, "Pharmacological Profile of CS-045, A New Orally Effective Antidiabetic Agent in Insulin Resistant Animal Models", (May 1988), Poster Session, vol. 37, Supplement 1, (ADA) New Orleans.
Anderson et al, "The Vasodilator Action of Insulin, Implications for the Insulin Hypothesis of Hypertension", Hypertension, vol. 21, No. 2 (Feb. 1993), pp. 136-141.
Baron et al, "Skeletal Muscle Blood Flow, A Possible Link Between Insulin Resistance and Blood Pressure", (Feb. 1993), pp. 129-135, Hypertension, vol. 21, No. 2.
Fujiwara et al, "Characterization of New Oral Antidiabetic Agent CS-045, Studies in KK and ob/ob Mice and Zucker Fatty Rats", (Nov. 1988), pp. 1549-1558, Diabetes, vol. 37.
Antonucci Tammy
Lockwood Dean
Norris Rebecca
Olefsky Jerrold
Raymond Richard L.
Sankyo Company Limited
LandOfFree
Use of thiazolidinedione derivatives and related antihyperglycem does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thiazolidinedione derivatives and related antihyperglycem, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thiazolidinedione derivatives and related antihyperglycem will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369536